Molecular mechanisms of cytochrome p450 induction: potential for drug-drug interactions.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Current protein and peptide science

• Publication date

  2007-11-30

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.2174/138920307783018668PMID 18220847
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CYP Induction-Mediated Drug Interactions: in Vitro Assessment and Clinical Implications

  2006cited by this paper
• Influence of rifampicin on the expression and function of human intestinal cytochrome P450 enzymes.

  2005cited by this paper
• Cytochrome P450 3A and their regulation

  2004cited by this paper
• Effect of Rifampin on the Pharmacokinetics of Rosiglitazone in Healthy Subjects

  2004cited by this paper
• Rifampicin, A Keystone Inducer of Drug Metabolism: From Herbert Remmer's Pioneering Ideas to Modern Concepts

  2004cited by this paper
• Activation of the Ah receptor by extracts of dietary herbal supplements, vegetables, and fruits.

  2003cited by this paper
• Characterization of hepatic cytochrome P4503A activity in patients with end‐stage renal disease

  2003cited by this paper
• Molecular mechanism of nuclear translocation of an orphan nuclear receptor, SXR.

  2003cited by this paper
• The environmental pollutant 1,1-dichloro-2,2-bis (p-chlorophenyl)ethylene induces rat hepatic cytochrome P450 2B and 3A expression through the constitutive androstane receptor and pregnane X receptor.

  2003cited by this paper
• Induction of drug-metabolizing enzymes: a path to the discovery of multiple cytochromes P450.

  2003cited by this paper
• Interactions of Herbs with Cytochrome P450

  2003cited by this paper
• Induction of Drug Metabolism: The Role of Nuclear Receptors

  2003cited by this paper
• The expression of CYP2B6, CYP2C9 and CYP3A4 genes: a tangle of networks of nuclear and steroid receptors.

  2003cited by this paper
• Relevance of induction of human drug-metabolizing enzymes: pharmacological and toxicological implications.

  2003cited by this paper
• Role of Orphan Nuclear Receptors in the Regulation of Drug-Metabolising Enzymes

  2003cited by this paper
• Origins of individual variability in P4501A induction.

  2003cited by this paper
• Nuclear receptor regulation of hepatic function.

  2002cited by this paper
• The nuclear pregnane X receptor: a key regulator of xenobiotic metabolism.

  2002cited by this paper
• Nuclear pregnane x receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification.

  2002cited by this paper
• Clinical importance of the cytochromes P450.

  2002cited by this paper
• Regulation of hepatic drug metabolism: role of the nuclear receptors PXR and CAR.

  2002cited by this paper
• The PXR crystal structure: the end of the beginning.

  2002cited by this paper
• A Structural Model of the Constitutive Androstane Receptor Defines Novel Interactions That Mediate Ligand-Independent Activity

  2002cited by this paper
• Polymorphisms in the human AH receptor.

  2002cited by this paper
• Regulation of cyp3a gene transcription by the pregnane x receptor.

  2002cited by this paper
• Expression of CYP3A4, CYP2B6, andCYP2C9 Is Regulated by the Vitamin D Receptor Pathway in Primary Human Hepatocytes*

  2002cited by this paper
• Conservation of signaling pathways of xenobiotic-sensing orphan nuclear receptors, chicken xenobiotic receptor, constitutive androstane receptor, and pregnane X receptor, from birds to humans.

  2001cited by this paper
• Hepatic cytochrome P450 regulation in disease states.

  2001cited by this paper
• Natural protein variants of pregnane X receptor with altered transactivation activity toward CYP3A4.

  2001cited by this paper
• The Human Nuclear Xenobiotic Receptor PXR: Structural Determinants of Directed Promiscuity

  2001cited by this paper
• Induction of CYP1A1. The AhR/DRE paradigm: transcription, receptor regulation, and expanding biological roles.

  2001cited by this paper
• Rifampin is a selective, pleiotropic inducer of drug metabolism genes in human hepatocytes: studies with cDNA and oligonucleotide expression arrays.

  2001cited by this paper
• Phenobarbital response elements of cytochrome P450 genes and nuclear receptors.

  2001cited by this paper
• Interindividual variability in inhibition and induction of cytochrome P450 enzymes.

  2001cited by this paper
• Cyp3A regulation: from pharmacology to nuclear receptors.

  2001cited by this paper
• Gene induction by Phenobarbital: an update on an old question that receives key novel answers.

  2001cited by this paper
• Dual effect of dexamethasone on CYP3A4 gene expression in human hepatocytes. Sequential role of glucocorticoid receptor and pregnane X receptor.

  2001cited by this paper
• Comparing nuclear receptors in worms, flies and humans.

  2001cited by this paper
• Herb-drug interactions.

  2000cited by this paper
• Induction and drug development.

  2000cited by this paper
• Regulation of cytochrome P450 (CYP) genes by nuclear receptors.

  2000cited by this paper
• Dexamethasone induces pregnane X receptor and retinoid X receptor-alpha expression in human hepatocytes: synergistic increase of CYP3A4 induction by pregnane X receptor activators.

  2000cited by this paper
• Human aryl hydrocarbon receptor nuclear translocator gene (ARNT) D/N511 polymorphism

  2000cited by this paper
• The pregnane X receptor: a promiscuous xenobiotic receptor that has diverged during evolution.

  2000cited by this paper
• Expression and induction of CYP1A1/1A2, CYP2A6 and CYP3A4 in primary cultures of human hepatocytes: a 10-year follow-up

  2000cited by this paper
• Enzyme induction in the elderly: Effect of rifampin on the pharmacokinetics and pharmacodynamics of propafenone

  2000cited by this paper
• The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism

  2000cited by this paper
• Interleukin-6 negatively regulates the expression of pregnane X receptor and constitutively activated receptor in primary human hepatocytes.

  2000cited by this paper
• Variation in induced CYP1A1 levels: relationship to CYP1A1, Ah receptor and GSTM1 polymorphisms.

  2000cited by this paper
• P450 gene induction by structurally diverse xenochemicals: central role of nuclear receptors CAR, PXR, and PPAR.

  1999cited by this paper
• Phenobarbital-Responsive Nuclear Translocation of the Receptor CAR in Induction of the CYP2B Gene

  1999cited by this paper
• Induction of CYP1A2 by phenobarbital in the livers of aryl hydrocarbon-responsive and -nonresponsive mice.

  1999cited by this paper
• Molecular mechanisms of cytochrome P-450 induction by xenobiotics: An expanded role for nuclear hormone receptors.

  1999cited by this paper
• Induction of cytochrome P4501A1.

  1999cited by this paper
• Insect P450 enzymes.

  1999cited by this paper
• The relationship among microsomal enzyme induction, liver weight and histological change in rat toxicology studies.

  1998cited by this paper
• Activation by diverse xenochemicals of the 51-base pair phenobarbital-responsive enhancer module in the CYP2B10 gene.

  1998cited by this paper
• The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions.

  1998cited by this paper
• TRANSCRIPTIONAL ACTIVATION OF CYTOCHROME P450 GENES BY DIFFERENT CLASSES OF CHEMICAL INDUCERS

  1998cited by this paper
• Inhibition and Induction of Cytochrome P450 and the Clinical Implications

  1998cited by this paper
• Characterization of a Phenobarbital-responsive Enhancer Module in Mouse P450 Cyp2b10 Gene*

  1997cited by this paper
• The structure, function, and regulation of cytochrome P450 2A enzymes.

  1997cited by this paper
• Regulation of cytochromes P450 during inflammation and infection.

  1997cited by this paper
• Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors.

  1997cited by this paper
• Ah receptor signaling pathways.

  1996cited by this paper
• Phenobarbital Induction Mediated by a Distal CYP2B2 Sequence in Rat Liver Transiently Transfected in Situ *

  1996cited by this paper
• Constitutive expression of hepatic cytochrome P450 genes

  1996cited by this paper
• Differential effects of cytokines on the inducible expression of CYP1A1, CYP1A2, and CYP3A4 in human hepatocytes in primary culture

  1995cited by this paper
• Effect of model inducers on cytochrome P450 activities of human hepatocytes in primary culture.

  1995cited by this paper
• Geographical/Interracial Differences in Polymorphic Drug Oxidation

  1995cited by this paper
• Structural determinants of nuclear receptor assembly on DNA direct repeats

  1995cited by this paper
• The aryl hydrocarbon receptor complex.

  1995cited by this paper
• Xenobiotic-inducible Transcription of Cytochrome P450 Genes (*)

  1995cited by this paper
• Dimerization interfaces formed between the DNA binding domains determine the cooperative binding of RXR/RAR and RXR/TR heterodimers to DR5 and DR4 elements.

  1994cited by this paper
• Specific and dose‐dependent enzyme induction by omeprazole in human beings

  1994cited by this paper
• Interindividual difference in expression of human Ah receptor and related P450 genes.

  1994cited by this paper
• Pharmacokinetic Drug Interactions with Rifampicin

  1992cited by this paper
• Phenobarbital induction of cytochrome P-450 gene expression.

  1992cited by this paper
• Induction of drug-metabolizing enzymes by xenobiotics.

  1990cited by this paper
• Enzyme induction in the cytochrome P-450 system.

  1990cited by this paper

• Artemisiae Argyi exosome-like nanovesicles alleviate ALF by reducing oxidative stress and inhibiting inflammation through the TLR4/NLRP3/Nrf2 axis

  2026cites this paper
• Clinical Therapy Dose Optimization of Sublingual Buprenorphine in Poorly Adherent Pregnant Patients: A PBPK Translational Modelling Study

  2024cites this paper
• The impact of pregnancy and associated hormones on the pharmacokinetics of Δ9-tetrahydrocannabinol

  2024cites this paper
• Epigenetic Mechanisms Contribute to Intraindividual Variations of Drug Metabolism Mediated by Cytochrome P450 Enzymes

  2023cites this paper
• Special Section on Perspective on Drug Metabolism and Disposition, Part I — Minireview Epigenetic Mechanisms Contribute to Intraindividual Variations of Drug Metabolism Mediated by Cytochrome P450 Enzymes

  2023cites this paper
• Exploring the Potential Toxicological Mechanisms of Vine Tea on the Liver Based on Network Toxicology and Transcriptomics

  2022cites this paper
• Accumulation, detoxification, and toxicity of dibutyl phthalate in the swimming crab.

  2021cites this paper
• Drug-Metabolizing Cytochrome P450 Enzymes Have Multifarious Influences on Treatment Outcomes

  2021cites this paper
• Structural insight into TNF-α inhibitors through combining pharmacophore-based virtual screening and molecular dynamic simulation

  2020cites this paper
• Sexual Dimorphism in Drug Metabolism and Pharmacokinetics.

  2020cites this paper
• Toxicological responses of BEAS‐2B cells to repeated exposures to benzene, toluene, m‐xylene, and mesitylene using air–liquid interface method

  2020cites this paper
• Responsiveness assessment of a 3D tetra-culture alveolar model exposed to diesel exhaust particulate matter.

  2018cites this paper
• A Transcriptional Regulatory Network Containing Nuclear Receptors and Long Noncoding RNAs Controls Basal and Drug-Induced Expression of Cytochrome P450s in HepaRG Cells

  2018cites this paper
• Phenobarbital Treatment at a Neonatal Age Results in Decreased Efficacy of Omeprazole in Adult Mice

  2017cites this paper
• Nrf2 is crucial for the down-regulation of Cyp7a1 induced by arachidonic acid in Hepg2 cells.

  2017cites this paper
• The role of drug-drug interactions in prostate cancer treatment: Focus on abiraterone acetate/prednisone and enzalutamide.

  2017cites this paper
• Effect of Omeprazole and Dextromethorphan on the Urinary Metabolic Ratio of Flurbiprofen.

  2016cites this paper
• Application of Static Models to Predict Midazolam Clinical Interactions in the Presence of Single or Multiple Hepatitis C Virus Drugs

  2016cites this paper
• Phenobarbital Treatment at a Neonatal Age Results in 1 Decreased Efficacy of Omeprazole in Adult Mice 2 3 4

  2016cites this paper
• A population-based analysis of the risk of drug interaction between clarithromycin and statins for hospitalisation or death

  2015cites this paper
• Cytochrome P450 1 family and cancers.

  2015cites this paper
• Variations in CYP isoforms and bladder cancer: a superfamily paradigm.

  2014influential citation
• Clinically relevant drug–drug interactions between antiretrovirals and antifungals

  2014cites this paper
• Pregnane X receptor agonists enhance intestinal epithelial wound healing and repair of the intestinal barrier following the induction of experimental colitis.

  2014cites this paper
• Effect of moxidectin on CYP3A4 activity as evaluated by oral midazolam pharmacokinetics in healthy subjects

  2014cites this paper
• INTERACTIONS BETWEEN DRUGS OF ABUSE AND HIV PROTEASE INHIBITORS

  2014cites this paper
• Capítulo 3 – Biotransformação

  2014cites this paper
• Cytochrome P450 2E1 Gene Polymorphisms/Haplotypes and Anti-Tuberculosis Drug-Induced Hepatitis in a Chinese Cohort

  2013cites this paper
• A Review of Herbal Interactions with Warfarin

  2013cites this paper
• Integrating Biomarkers of Organophosphate Pesticides in an Agriculturally Exposed Population

  2013cites this paper
• Experimental nonalcoholic fatty liver disease in mice leads to cytochrome p450 2a5 upregulation through nuclear factor erythroid 2-like 2 translocation

  2013cites this paper
• Drug Interaction Assessment Strategies: Small Molecules versus Therapeutic Proteins

  2013cites this paper
• Pharmacokinetic interactions of selective serotonin reuptake inhibitors with other commonly prescribed drugs in the era of pharmacogenomics

  2012cites this paper
• Drug Interactions with Herbal Medicines

  2012cites this paper
• In Vitro Liver Systems to Study Induction/Inhibition: Prediction of In Vivo Metabolism and Drug–Drug Interactions

  2012cites this paper
• Evaluation of Drug–Drug Interaction Risk with PBPK Models

  2012cites this paper
• ADMEt Evaluation of Anti-tuberculosis Compounds and New Methodologies Development

  2011influential citation
• Variabilité pharmacocinétique de la névirapine et de l’éfavirenz et rôle du polymorphisme des enzymes et transporteurs dans une population de patients cambodgiens infectés par le VIH et traités par une association d’antirétroviraux comprenant névirapine ou éfavirenz

  2011cites this paper
• Dioxin toxicity, aryl hydrocarbon receptor signaling, and apoptosis—Persistent pollutants affect programmed cell death

  2011cites this paper
• Lanford medium induces high quality hepatic lineage cell differentiation directly from mouse embryonic stem cell-derived mesendoderm.

  2010cites this paper
• Inhaled Anesthetics: Metabolism and Toxicity

  2010cites this paper
• Cytochrome P450 2A5 constitutive expression and induction by heavy metals is dependent on redox-sensitive transcription factor Nrf2 in liver.

  2010cites this paper
• Enzyme induction: translating multiple approaches, assays, endpoints, and opinions into a valuable induction screening strategy.

  2010cites this paper
• Modulation of ascorbic acid metabolism by cytochrome P450 induction revealed by metabonomics and transcriptional profiling

  2009cites this paper
• Towards a quantitative framework for the prediction of DDIs arising from cytochrome P450 induction.

  2009cites this paper
• Sex Differences in the Expression of Hepatic Drug Metabolizing Enzymes

  2009cites this paper
• Biomarkers of oxidative stress and damage in human populations exposed to arsenic.

  2009cites this paper
• NSAIDs (Non-steroidal anti-inflammatory drugs) とメトホルミン内服により急性腎不全, 低血糖および乳酸アシドーシスを発症した先天性副腎過形成を有した2型糖尿病患者の1例

  2009cites this paper